GLP-1 RAs can decrease the risk for developing early-onset colorectal cancer (EO-CRC) in patients with diabetes regardless of weight.

Vaginoplasty is associated with a high incidence of postoperative UTI and SSI, as well as significant gaps in HIV screening and PrEP prescribing.

Obesity is associated with self-reported symptoms of depression, eating disorders, and/or binge eating among treatment-seeking adolescents.

FSH levels were independently associated with an increased risk for hip fracture among older men and women regardless of bone density.

In the current study, patients with rheumatoid arthritis achieved a 59.4% success rate with methotrexate monotherapy. Patients with rheumatoid arthritis (RA) achieved a 59.4% success rate with ...

The FDA has issued a warning regarding compounded drugs distributed by Fullerton Wellness, LLC, in Ontario, California.

Irregular sleep patterns, regardless of meeting recommended sleep durations, were associated with increased risk for type 2 diabetes.

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.

SHBG levels were inversely associated with fracture risk among men, whereas testosterone demonstrated a non-linear relationship.

Heterozygous familial hypercholesterolemia was associated with increased type 2 diabetes risk, especially among those with obesity and statin use.

Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

Sotagliflozin is an oral dual sodium-glucose co-transporter types 1 and 2 (SGLT1/SGLT2) inhibitor. The FDA panel voted against the approval of sotagliflozin for patients with type 1 diabetes and ...